Liontown Resources Ltd has amended its loan and spodumene supply agreements with Ford Motor Co., a strategic move designed to enhance liquidity and increase flexibility as production accelerates at its Kathleen Valley lithium project in Western Australia. The revised deal defers principal and interest payments due to Ford by 12 months, covering fiscal 2026, while keeping all other loan conditions unchanged.
The update also significantly reduces the remaining spodumene concentrate volumes committed to Ford from 2027 onwards — halved to 256,250 dry metric tons. Notably, there will be no deliveries in 2027 or 2028, giving Liontown more leeway to sell on the spot market or explore new strategic partnerships. Ford will also have the option to waive its take-or-pay commitments for these future volumes.
Following the announcement, Liontown’s shares surged 3.4% to A$1.065, their highest level since mid-June 2024, outperforming the S&P/ASX 200 index, which rose just 0.3%. The market reaction reflects investor confidence in the company’s financial resilience and operational strategy amid a volatile lithium market.
Liontown emphasized that the amendments strengthen its near-term liquidity as it ramps up output at Kathleen Valley, one of Australia’s most significant emerging lithium projects. The move comes just a week after the Perth-based miner said it was renegotiating pricing terms with Tesla, aiming to align long-term offtake agreements with evolving lithium benchmark prices.
By revising its deals with two major EV manufacturers, Liontown is positioning itself to capitalize on favorable market dynamics and secure greater exposure to fluctuating lithium prices. These strategic adjustments could enhance the company’s competitive standing in the global battery materials sector as demand for electric vehicles and lithium intensifies.


Luxury Car Sales in the Middle East Take a Hit Amid Iran War
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Apple Turns 50: From Garage Startup to AI Crossroads
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
First Western Ship Transits Strait of Hormuz Since Iran War Began
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push 



